Compounds > pomalidomide
Page last updated: 2024-09-04

pomalidomide and Carcinoma, Non-Small Cell Lung

pomalidomide has been researched along with Carcinoma, Non-Small Cell Lung in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Qi, Z; Wang, X; Zhao, Y1

Other Studies

1 other study(ies) available for pomalidomide and Carcinoma, Non-Small Cell Lung

ArticleYear
LY103, a pomalidomide derivative, alleviates taxol resistance in NSCLC via energy metabolism crosstalk and tumor microenvironment intervention.
    Bioorganic chemistry, 2023, Volume: 136

    Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Energy Metabolism; Humans; Lung Neoplasms; Molecular Docking Simulation; Paclitaxel; Tumor Microenvironment

2023